RJFSA
GMAB icon

Raymond James Financial Services Advisors’s Genmab GMAB Stock Holding History

Raymond James Financial Services Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,167
Closed -$202K – 3338
2021
Q1 		$202K Sell
6,167
-412
-6% -$15.5K ﹤0.01% 2902
2020
Q4 		$268K Buy
6,579
+259
+4% +$9.68K ﹤0.01% 2532
2020
Q3 		$231K Buy
+6,320
New +$229K ﹤0.01% 2451

Other funds holding GMAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Raymond James Financial Services Advisors's GMAB Position: Q2 2021 in Review

Raymond James Financial Services Advisors sold out of Genmab (GMAB) in Q2 2021, closing a stake of 6,167 shares — an estimated $202K sold.

Raymond James Financial Services Advisors first reported a position in GMAB in Q3 2020 and held it in 3 quarters. The position peaked at $268K in Q4 2020. 212 funds tracked by Wall St. Rank hold GMAB as of Q2 2021.

  • Raymond James Financial Services Advisors reported no remaining Genmab position as of Q2 2021 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 6,167 Genmab shares in Q2 2021, an estimated $202K.
  • Raymond James Financial Services Advisors first reported a position in Genmab in Q3 2020 and held it in 3 quarters.
  • Raymond James Financial Services Advisors's Genmab position peaked at $268K in Q4 2020.
  • 212 funds tracked by Wall St. Rank held Genmab as of Q2 2021.

Based on Raymond James Financial Services Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.